CA2038497A1 - Derives de lipopeptides - Google Patents

Derives de lipopeptides

Info

Publication number
CA2038497A1
CA2038497A1 CA002038497A CA2038497A CA2038497A1 CA 2038497 A1 CA2038497 A1 CA 2038497A1 CA 002038497 A CA002038497 A CA 002038497A CA 2038497 A CA2038497 A CA 2038497A CA 2038497 A1 CA2038497 A1 CA 2038497A1
Authority
CA
Canada
Prior art keywords
compound
hydroxy
acid
ester
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002038497A
Other languages
English (en)
Inventor
Milton L. Hammond
James M. Balkovec
Robert E. Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CA2038497A1 publication Critical patent/CA2038497A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002038497A 1990-03-19 1991-03-18 Derives de lipopeptides Abandoned CA2038497A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49519990A 1990-03-19 1990-03-19
US495,199 1990-03-19

Publications (1)

Publication Number Publication Date
CA2038497A1 true CA2038497A1 (fr) 1991-09-20

Family

ID=23967674

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002038497A Abandoned CA2038497A1 (fr) 1990-03-19 1991-03-18 Derives de lipopeptides

Country Status (11)

Country Link
EP (1) EP0448343A3 (fr)
JP (1) JPH07121957B2 (fr)
KR (1) KR910016771A (fr)
AU (1) AU7358591A (fr)
CA (1) CA2038497A1 (fr)
FI (1) FI911308A (fr)
IE (1) IE910893A1 (fr)
IL (1) IL97347A0 (fr)
NO (1) NO911065L (fr)
PT (1) PT97043A (fr)
ZA (1) ZA911978B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
CZ288974B6 (cs) * 1992-03-19 2001-10-17 Eli Lilly And Company Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
DE69419544T2 (de) * 1993-02-23 1999-11-25 Hitachi, Ltd. Wirbelstromgebläse und Schaufelrad
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (fr) 1998-08-20 2005-01-26 Eli Lilly & Company Synthese des analogues peptidiques cycliques a systeme cyclique modifie
CA2362481C (fr) 1999-03-03 2008-11-04 Eli Lilly And Company Formulations pharmaceutiques d'echinocandine contenant des tensioactifs formant des micelles
WO2000052037A1 (fr) 1999-03-03 2000-09-08 Eli Lilly And Company Complexes d'echinocandine/glucide
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2065130A (en) * 1979-12-13 1981-06-24 Lilly Co Eli Recovery process for a-30912 antibiotics

Also Published As

Publication number Publication date
FI911308A0 (fi) 1991-03-18
JPH07121957B2 (ja) 1995-12-25
IE910893A1 (en) 1991-09-25
PT97043A (pt) 1991-10-31
FI911308A (fi) 1991-09-20
JPH04217699A (ja) 1992-08-07
NO911065D0 (no) 1991-03-18
AU7358591A (en) 1993-01-28
IL97347A0 (en) 1992-05-25
NO911065L (no) 1991-09-20
KR910016771A (ko) 1991-11-05
ZA911978B (en) 1991-12-24
EP0448343A3 (en) 1992-01-22
EP0448343A2 (fr) 1991-09-25

Similar Documents

Publication Publication Date Title
US5330973A (en) Lipopeptide derivatives
US5166135A (en) Method for the control of pneumocystis carinii
EP0359529B1 (fr) Méthode de contrôle de Pneumocystis carinii
US4931352A (en) Antifungal fermentation product
US5021341A (en) Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
CA2038497A1 (fr) Derives de lipopeptides
US5310726A (en) Lipopeptide compounds
US5741775A (en) Cyclohexapeptidyl aminoalkyl ethers
US5386009A (en) Lipopeptide derivatives
US5369093A (en) Lipopeptide derivatives
US5198421A (en) Phosphorylated cyclic lipopeptide
US5386010A (en) Lipopeptide compounds
AU639698B2 (en) Antibiotic agent
EP0311193B1 (fr) Produit de fermentation fongicide
US5939384A (en) Cyclohexapeptidyl propanolamine compounds
US5428009A (en) Lipopeptide derivatives
CA2057711C (fr) Agent antibiotique
US5385884A (en) Lipopeptide derivatives
US5399552A (en) Antibiotic peptides bearing aminoalkylthioether moieties
EP0539088B1 (fr) Dérivé d'échinocandine B
US6331521B1 (en) Echinocandine derivatives with antimicrobial activity
US5348940A (en) Cyclohexapeptidyl hydroxypropionitrile compounds
US5430018A (en) Cyclohexapeptide with basic nitrogen containing alkylamide groups

Legal Events

Date Code Title Description
FZDE Discontinued